This week China imposed tariffs on imports of various U.S. agricultural products in retaliation for Trump Administration tariffs on Chinese imports. Today the Administration announced that it would consider an additional $100 billion in tariffs on Chinese goods in response.
The impact of the Chinese tariffs on U.S. exports of pork meat, cherries, almonds, and ginseng, among other items, was detailed in a new brief from the Congressional Research Service. See China’s Retaliatory Tariffs on Selected U.S. Agricultural Products, CRS Insight, April 4, 2018.
Other new and updated reports from the Congressional Research Service this week include the following.
U.S. Trade Deficit and the Impact of Changing Oil Prices, updated April 4, 2018
Immigration Consequences of Criminal Activity, April 5, 2018
Federal Research and Development (R&D) Funding: FY2019, April 4, 2018
Title I of the Toxic Substances Control Act (TSCA): A Summary of the Statute, April 4, 2018
Data, Social Media, and Users: Can We All Get Along?, CRS Insight, April 4, 2018
Abortion and Family Planning-Related Provisions in U.S. Foreign Assistance Law and Policy, updated April 5, 2018
Nuclear Cooperation with Other Countries: A Primer, updated April 3, 2018
What Happens When Five Supreme Court Justices Can’t Agree?, CRS Legal Sidebar, April 5, 2018
As humans expand our geographic reach, encroach on untouched natural territories, and interact more with animal populations, we will encounter novel zoonotic diseases that threaten the human body. The sooner we act to address these risks, the better.
This report serves as a landscape assessment and toolbox from which local governments can negotiate an informed position when it comes to the levers available to them and includes a first-of-its kind analysis of eight executed community benefits agreements.
When a hurricane hits, it’s all hands on deck – that goes for federal data, too. Pulling back from our investments in timely, accurate, and accessible public data will only make us less prepared and put us all at greater risk.
This is bigger than a singular elimination of race and ethnicity questions. It could accelerate the second wave of widespread reductions to demographic data, leaving public health officials with even less information to deliver better health outcomes for all Americans.